Paul W Harms
Clinical Professor of Pathology
Clinical Professor of Dermatology, Medical School
Email:
[email protected]
Available to mentor
Paul W Harms
Clinical Professor
Manage Your Profile
About
Dr. Paul Harms is a board-certified pathologist and dermatopathologist.
Research Overview
Dr. Harms has interested in molecular markers and mechanisms of cutaneous diseases, especially cutaneous neoplasia. His work has advanced understanding of the genomic drivers of multiple skin malignancies, especially Merkel cell carcinoma.
Recent Publications
-
Jiang R, Kirma J, Fox J, Xing X, Wang J, Sarkar MK, Bogle R, Do T, Coon A, Cole C, Plazyo O, Rew JE, Zhang H, Kahlenberg JM, Billi AC, Bachelez H, Tsoi LC, Harms PW, Shao S, Chen X, Gudjonsson JE. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleDynamic neutrophil-keratinocyte communication network centered on IL-36/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis
DOI:10.1038/s41467-025-67917-9 PMID: 41436466 -
Jiang R, Bogle R, Xing X, Kirma J, Fox J, Harms PW, Do T, Billi AC, Kahlenberg JM, Modlin RL, Teles R, West J, Mangold A, Zhang H, Schneider MA, Bruno S, Roediger B, Martiny-Baron G, Tsoi LC, Hacini-Rachinel F, Röhn TA, Gudjonsson JE. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleSingle-cell and spatial profiling reveal cDC2A-CXCL13+CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus
DOI:10.1038/s41467-026-70506-z PMID: 41832141 -
Durgin JS, Wiedemeyer K, Wang G, Bresler SC, Hrycaj SM, van der Weyden L, Adams DJ, Brenn T, Harms PW. J Cutan Pathol, 2026 Nov 5;Journal ArticleDiagnostic Utility of p16 and MTAP Immunohistochemistry for Cellular Neurothekeomas.
DOI:10.1111/cup.70243 PMID: 42988455 -
Velasco-Herrera MDC, Cheema S, Wong K, Billington J, Vermes I, Anderson E, Ferla E, Harms PW, de Saint Aubain N, Clarke EL, Merchant W, Alomari AK, Rajan N, Ferguson P, Weigelt MA, Monteagudo C, Billings SD, Arends MJ, Ferreira I, Brenn T, van der Weyden L, Adams DJ. Journal of Investigative Dermatology, 2026 Oct 1; 146 (10): 2889 - 2892.Journal ArticleCARMN fusions and PDGFRB mutations highlight key differences among cutaneous tumors with myopericytic differentiation
DOI:10.1016/j.jid.2026.04.036 PMID: 42140550 -
Plotzke JM, Wang G, Bresler SC, Harms PW. Cancers, 2026 Oct 1; 18 (20):Journal ArticleMolecular Diagnosis of Melanocytic Neoplasia: Updates and Challenges
DOI:10.3390/cancers18203330 -
Lee O, Breglio K, Harms K. 2025 May 5;Journal ArticleExtensive basal cell carcinoma tracking along nasal mucosa at the site of nose piercing
-
Jiang R, Bogle R, Xing X, Chen L, Fox J, Harms PW, Nakamura M, Fonquerna S, Kahlenberg M, Tsoi LC, Uluckan O, Gudjonsson JE. Journal of Investigative Dermatology, 2026 Jul 22; 146 (8): s4Proceeding / Abstract / Poster0024 Single-cell and spatial analyses identify a TNFSF14-driven S100A8high monocyte–Th17–keratinocyte axis in early hidradenitis suppurativa
DOI:10.1016/j.jid.2026.06.055 -
Chen L, Jiang R, Bogle R, Kirma J, Fox J, Billi A, Zhang L, Kahlenberg M, Harms PW, Shao S, Tsoi LC, Gudjonsson JE. Journal of Investigative Dermatology, 2026 Jul 23; 146 (8): s7Proceeding / Abstract / Poster0038 Early immune circuits in guttate psoriasis reveal pathways governing disease resolution and progression
DOI:10.1016/j.jid.2026.06.069